Kunle O. Odunsi - Search Results

Year	Number of Results
2009	1
2012	1
2014	1
2015	3
2016	2
2018	1
2019	2
2020	1
2022	1
2023	1
2024	0

1

Reprogramming the tumor microenvironment leverages CD8⁺ T cell responses to a shared tumor/self antigen in ovarian cancer.

Mistarz A, Winkler M, Battaglia S, Liu S, Hutson A, Rokita H, Gambotto A, Odunsi KO, Singh PK, McGray AJR, Wang J, Kozbor D. Mistarz A, et al. Among authors: odunsi ko. Mol Ther Oncolytics. 2023 Feb 9;28:230-248. doi: 10.1016/j.omto.2023.02.002. eCollection 2023 Mar 16. Mol Ther Oncolytics. 2023. PMID: 36875325 Free PMC article.

2

Whole-exome sequencing of ovarian cancer families uncovers putative predisposition genes.

Zhu Q, Zhang J, Chen Y, Hu Q, Shen H, Huang RY, Liu Q, Kaur J, Long M, Battaglia S, Eng KH, Lele SB, Zsiros E, Villella J, Lugade A, Yao S, Liu S, Moysich K, Odunsi KO. Zhu Q, et al. Among authors: odunsi ko. Int J Cancer. 2020 Apr 15;146(8):2147-2155. doi: 10.1002/ijc.32545. Epub 2019 Jul 16. Int J Cancer. 2020. PMID: 31265121 Free PMC article.

3

Aspirin and Acetaminophen Use and the Risk of Cervical Cancer.

Friel G, Liu CS, Kolomeyevskaya NV, Hampras SS, Kruszka B, Schmitt K, Cannioto RA, Lele SB, Odunsi KO, Moysich KB. Friel G, et al. Among authors: odunsi ko. J Low Genit Tract Dis. 2015 Jul;19(3):189-93. doi: 10.1097/LGT.0000000000000104. J Low Genit Tract Dis. 2015. PMID: 25856123 Free PMC article.

4

Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC).

Oturkar CC, Gandhi N, Rao P, Eng KH, Miller A, Singh PK, Zsiros E, Odunsi KO, Das GM. Oturkar CC, et al. Among authors: odunsi ko. Cancers (Basel). 2022 Feb 22;14(5):1120. doi: 10.3390/cancers14051120. Cancers (Basel). 2022. PMID: 35267428 Free PMC article.

5

Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study.

Eng KH, Szender JB, Etter JL, Kaur J, Poblete S, Huang RY, Zhu Q, Grzesik KA, Battaglia S, Cannioto R, Krolewski JJ, Zsiros E, Frederick PJ, Lele SB, Moysich KB, Odunsi KO. Eng KH, et al. Among authors: odunsi ko. PLoS Genet. 2018 Feb 15;14(2):e1007194. doi: 10.1371/journal.pgen.1007194. eCollection 2018 Feb. PLoS Genet. 2018. PMID: 29447163 Free PMC article.

6

Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.

Grzankowski KS, Szender JB, Spring-Robinson CL, Lele SB, Odunsi KO, Frederick PJ. Grzankowski KS, et al. Among authors: odunsi ko. Int J Gynecol Cancer. 2016 Oct;26(8):1440-7. doi: 10.1097/IGC.0000000000000785. Int J Gynecol Cancer. 2016. PMID: 27648713 Free PMC article.

7

Recruitment of Intratumoral CD103⁺ Dendritic Cells by a CXCR4 Antagonist-Armed Virotherapy Enhances Antitumor Immunity.

Mistarz A, Komorowski MP, Graczyk MA, Gil M, Jiang A, Opyrchal M, Rokita H, Odunsi KO, Kozbor D. Mistarz A, et al. Among authors: odunsi ko. Mol Ther Oncolytics. 2019 Jul 3;14:233-245. doi: 10.1016/j.omto.2019.06.003. eCollection 2019 Sep 27. Mol Ther Oncolytics. 2019. PMID: 31384667 Free PMC article.

8

Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy.

Komorowski MP, McGray AR, Kolakowska A, Eng K, Gil M, Opyrchal M, Litwinska B, Nemeth MJ, Odunsi KO, Kozbor D. Komorowski MP, et al. Among authors: odunsi ko. Mol Ther Oncolytics. 2016 Dec 14;3:16034. doi: 10.1038/mto.2016.34. eCollection 2016. Mol Ther Oncolytics. 2016. PMID: 28035333 Free PMC article.

9

Higher than expected frequencies of non-ovarian cancers within a large familial ovarian cancer registry.

Brightwell RM, Grzankowski KS, Kaur J, Poblete S, Miller A, Lele SB, Sucheston-Campbell L, Moysich K, Odunsi KO. Brightwell RM, et al. Among authors: odunsi ko. Am J Clin Exp Obstet Gynecol. 2015;2(1):39-44. Epub 2015 Feb 15. Am J Clin Exp Obstet Gynecol. 2015. PMID: 26605374 Free PMC article.

10

CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.

Gil M, Komorowski MP, Seshadri M, Rokita H, McGray AJ, Opyrchal M, Odunsi KO, Kozbor D. Gil M, et al. Among authors: odunsi ko. J Immunol. 2014 Nov 15;193(10):5327-37. doi: 10.4049/jimmunol.1400201. Epub 2014 Oct 15. J Immunol. 2014. PMID: 25320277 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year